GILEAD SCIENCES, INC. Marketable Securities (Non-Current)
GILEAD SCIENCES, INC. (GILD) had Marketable Securities (Non-Current) of $0 as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:MarketableSecuritiesNoncurrent · last filed 2026-08-06
- 2026-06-30: Marketable Securities, Noncurrent $0.00.
- 2026-03-31: Marketable Securities, Noncurrent $983.00M.
- 2025-12-31: Marketable Securities, Noncurrent $2.97B.
- 2025-09-30: Marketable Securities, Noncurrent $2.00B.
| Period end | Marketable Securities, Noncurrent | Marketable Securities, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $983.00M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $2.97B 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $2.00B 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $1.91B 10-Q · filed 2025-08-07 | |
| 2024-12-31 | $0.00 10-K · filed 2026-02-24 | |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $1.16B 10-K · filed 2025-02-28 | |
| 2023-09-30 | $1.16B 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $1.33B 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $1.33B 10-Q · filed 2023-05-03 | |
| 2022-12-31 | $1.25B 10-K · filed 2024-02-23 | |
| 2022-09-30 | $1.28B 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $1.34B 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $1.43B 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $1.31B 10-K · filed 2023-02-22 | |
| 2021-09-30 | $1.10B 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $836.00M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $579.00M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $502.00M 10-K · filed 2022-02-23 | |
| 2020-09-30 | $2.07B 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $2.28B 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $3.53B 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $1.49B 10-K · filed 2021-02-25 | |
| 2019-09-30 | $2.19B 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $3.05B 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $2.22B 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $1.42B 10-K · filed 2020-02-25 | |
| 2018-09-30 | $2.38B 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $5.74B 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $8.10B 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $11.18B 10-K · filed 2019-02-26 | |
| 2017-09-30 | $12.97B 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $15.48B 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $19.90B 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $20.48B 10-K · filed 2018-02-27 | |
| 2016-09-30 | $19.34B 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $15.86B 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $13.00B 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $11.60B 10-K · filed 2017-02-27 | |
| 2015-09-30 | $9.40B 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $6.06B 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $3.22B 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $1.60B 10-K · filed 2016-02-24 | |
| 2014-09-30 | $1.38B 10-Q · filed 2014-11-05 | |
| 2014-06-30 | $782.32M 10-Q · filed 2014-08-04 | |
| 2014-03-31 | $389.87M 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $439.00M 10-K · filed 2015-02-25 | $439.03M 10-K · filed 2014-02-25 |
| 2013-03-31 | $688.25M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $719.84M 10-K · filed 2014-02-25 | |
| 2012-09-30 | $955.60M 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $564.13M 10-Q · filed 2012-08-01 | |
| 2012-03-31 | $48.17M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $63.70M 10-K · filed 2013-02-27 | |
| 2011-09-30 | $3.22B 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $3.23B 10-Q · filed 2011-08-05 | |
| 2011-03-31 | $3.34B 10-Q · filed 2011-05-09 | |
| 2010-12-31 | $3.22B 10-K · filed 2012-02-23 | |
| 2010-09-30 | $2.74B 10-Q · filed 2010-11-08 | |
| 2010-06-30 | $2.22B 10-Q · filed 2010-08-09 | |
| 2010-03-31 | $2.97B 10-Q · filed 2010-05-10 | |
| 2009-12-31 | $2.25B 10-K · filed 2011-02-28 | |
| 2009-09-30 | $1.94B 10-Q · filed 2009-11-05 | |
| 2009-06-30 | $1.65B 10-Q · filed 2009-08-05 | |
| 2008-12-31 | $1.45B 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |